NEWRON PHARMA N - 1H - Technical analysis published on 01/15/2024 (GMT)
- 98
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
Analysis too old. There are no more charts available.
Summary of the analysis
Additional analysis
Quotes
The NEWRON PHARMA N rating is 10.8500 CHF. On the day, this instrument gained +9.82% and was between 9.7400 CHF and 11.4500 CHF. This implies that the price is at +11.40% from its lowest and at -5.24% from its highest.A bullish opening was detected by the Central Gaps scanner. Buyers are trying to impose a bullish momentum in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by NEWRON PHARMA N:
New HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
New HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
New HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
New HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
The Central Volumes scanner detects abnormal volumes on the asset:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of this 1H chart of NEWRON PHARMA N indicates that the overall trend is strongly bullish. 92.86% of the signals given by moving averages are bullish. This strongly bullish trend is supported by the strong bullish signals given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
An assessment of technical indicators shows a strong bullish signal.
Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 80
Type : Neutral
Timeframe : 1 hour
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Weekly
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
The presence of a bullish Japanese candlestick pattern detected by Central Candlesticks that could cause a very short term rebound was also detected:
Long white line
Type : Bullish
Timeframe : 1 hour
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 7.5200 | 8.0583 | 9.0000 | 10.8500 | 13.8133 | 27.8000 | 35.0000 |
Change (%) | -30.69% | -25.73% | -17.05% | - | +27.31% | +156.22% | +222.58% |
Change | -3.3300 | -2.7917 | -1.8500 | - | +2.9633 | +16.9500 | +24.1500 |
Level | Minor | Intermediate | Minor | - | Minor | Minor | Major |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 7.0867 | 7.7533 | 8.8167 | 9.4833 | 10.5467 | 11.2133 | 12.2767 |
Camarilla | 9.4043 | 9.5628 | 9.7214 | 9.8800 | 10.0386 | 10.1972 | 10.3558 |
Woodie | 7.2850 | 7.8525 | 9.0150 | 9.5825 | 10.7450 | 11.3125 | 12.4750 |
Fibonacci | 7.7533 | 8.4142 | 8.8225 | 9.4833 | 10.1442 | 10.5525 | 11.2133 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 3.2200 | 4.6600 | 7.2700 | 8.7100 | 11.3200 | 12.7600 | 15.3700 |
Camarilla | 8.7663 | 9.1375 | 9.5088 | 9.8800 | 10.2513 | 10.6225 | 10.9938 |
Woodie | 3.8050 | 4.9525 | 7.8550 | 9.0025 | 11.9050 | 13.0525 | 15.9550 |
Fibonacci | 4.6600 | 6.2071 | 7.1629 | 8.7100 | 10.2571 | 11.2129 | 12.7600 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 3.2367 | 3.7433 | 4.3467 | 4.8533 | 5.4567 | 5.9633 | 6.5667 |
Camarilla | 4.6448 | 4.7465 | 4.8483 | 4.9500 | 5.0518 | 5.1535 | 5.2553 |
Woodie | 3.2850 | 3.7675 | 4.3950 | 4.8775 | 5.5050 | 5.9875 | 6.6150 |
Fibonacci | 3.7433 | 4.1674 | 4.4293 | 4.8533 | 5.2774 | 5.5393 | 5.9633 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 84.36 | |
MACD (12,26,9): | 0.6644 | |
Directional Movement: | 41.8621 | |
AROON (14): | 64.2857 | |
DEMA (21): | 10.0826 | |
Parabolic SAR (0,02-0,02-0,2): | 8.9273 | |
Elder Ray (13): | 1.0249 | |
Super Trend (3,10): | 9.1631 | |
Zig ZAG (10): | 10.9000 | |
VORTEX (21): | 1.1822 | |
Stochastique (14,3,5): | 80.46 | |
TEMA (21): | 10.2237 | |
Williams %R (14): | -18.15 | |
Chande Momentum Oscillator (20): | 2.0400 | |
Repulse (5,40,3): | 11.3565 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 1.0277 | |
Courbe Coppock: | 29.71 |
MA7: | 8.3543 | |
MA20: | 5.9750 | |
MA50: | 5.2644 | |
MA100: | 5.2744 | |
MAexp7: | 9.9416 | |
MAexp20: | 9.2165 | |
MAexp50: | 8.1010 | |
MAexp100: | 7.0137 | |
Price / MA7: | +29.87% | |
Price / MA20: | +81.59% | |
Price / MA50: | +106.10% | |
Price / MA100: | +105.71% | |
Price / MAexp7: | +9.14% | |
Price / MAexp20: | +17.72% | |
Price / MAexp50: | +33.93% | |
Price / MAexp100: | +54.70% |
News
The latest news and videos published on NEWRON PHARMA N at the time of the analysis were as follows:
- EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)
- EQS-News: Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide
- EQS-News: Newron TRS study 6 months’ results: Evenamide substantially improves patients to an extent that they no longer meet protocol entry criteria
- EQS-News: Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress
- EQS-News: Newron appoints Margarita Chavez as board advisor
Add a comment
Comments
0 comments on the analysis NEWRON PHARMA N - 1H